00882 TIANJIN DEV
- 1.720
- +0.010+0.58%
TIANJIN DEV News
TIANJIN DEV: Unaudited Financial Results for the three months ended 31 March 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.
TIANJIN DEV: Notification Letter to Non-registered Shareholders and Request Form
TIANJIN DEV: Notification Letter to Existing Shareholders and Request Form
TIANJIN DEV: Notice of Annual General Meeting
TIANJIN DEV: Form of Proxy for Annual General Meeting to be held on 13 June 2024
TIANJIN DEV: General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors, Proposed Adoption of the New Articles of Association and Notice of Annual General Meeting
TIANJIN DEV: Annual Report 2023
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
TIANJIN DEV: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
TIANJIN DEV: List of Directors and their Roles and Functions
TIANJIN DEV: Change of Chairman of the Board, Authorised Representative and Change in Composition of Nomination Committee, Remuneration Committee and Investment Committee
TIANJIN DEV: Final Dividend for the year ended 31 December 2023
TIANJIN DEV: Annoucement of Final Results for the year ended 31 December 2023
TIANJIN DEV: Audited Financial Results for the year ended 31 December 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.
TIANJIN DEV: Date of Board Meeting
TIANJIN DEV: Material Variation of the Terms of Connected Transaction in relation to the Partnership Agreement
TIANJIN DEV: Positive Profit Alert
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
TIANJIN DEV: Overseas Regulatory Announcement
TIANJIN DEV: Announcement Pursuant to Rule 13.18 of the Listing Rules
Analysis
Price Target
No Data
